Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYJunshi Biosciences Announces Acceptance by the NMPA of Supplemental New Drug Application for Toripalimab Combined with Chemotherapy for The First-Line Treatment of Nasopharyngeal CarcinomaPREV STORYAscendis Pharma A/S Announces Participation at SVB Leerink 10th Annual Global Healthcare Conference